Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 424B2: Prospectus
Eli Lilly and Co | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Eli Lilly and Co | 424B2: Prospectus
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144
Eli Lilly and Co | 424B2: Prospectus
No Data
No Data